BML (BMLKF) YoY EBITDA Growth: 14.53% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BMLKF BML Inc BMLKF
73 GF Score
Price $25.21
GF Value $26.96
! 2 Warning Signs
View Full Analysis

What is BML YoY EBITDA Growth?

BML BMLKF 73 YoY EBITDA Growth is 14.53% as of Mar. 2026. GuruFocus rates BMLKF with a GF Score™ of 73/100 and a GF Value™ of $26.96. The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BML's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 14.53%.

BML's EBITDA per Share for the three months ended in Mar. 2026 was $1.82.

BML YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for BML's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML YoY EBITDA Growth Chart

BML Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.71 -50.45 -51.74 7.73 16.67

BML Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -55.29 14.53 0.19
BMLKF
73GF Score
BML Inc BMLKF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BML YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BML's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(3.513-3.011)/ | 3.011 |
=16.67 %

BML's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(1.821-1.59)/ | 1.59 |
=14.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 14.53% mean?
BML (BMLKF) has a YoY EBITDA Growth of 14.53% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for BML and its competitors.
Is BML's YoY EBITDA Growth too high?
BML's current YoY EBITDA Growth is 14.53%. Overall, BML has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does BML's YoY EBITDA Growth compare to TMO and DHR?
BML's YoY EBITDA Growth of 14.53% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Diagnostics & Research company?
A good YoY EBITDA Growth depends on the Medical Diagnostics & Research industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for BML and its competitors. BML's current YoY EBITDA Growth is 14.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current YoY EBITDA Growth of 14.53%. The stock's GF Value™ is $26.96, compared to a current price of $25.21 — trading 6.5% below its estimated fair value. The current YoY EBITDA Growth is 14.53%. BML's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For BML (BMLKF), the current YoY EBITDA Growth is 14.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (BMLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of $25.21 is trading 6.5% below its estimated GF Value™ of $26.96.

Key valuation signals for BMLKF:

  • YoY EBITDA Growth: 14.53%
  • GF Value™: $26.96 vs. price of $25.21 (6.5% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BML Business Description

Other Exchanges 4694:Japan
Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
73GF Score

Get the complete analysis for BMLKF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.21
Price
$26.96
GF Value